Internal Medicine
GLP-1 Weight-Loss Injections: The Complete Guide to Mounjaro, Wegovy, and Ozempic
Reviewed by the JordanMedHub Medical Editorial Team · 8/29/2026
Quick Answer
How GLP-1 medications like Mounjaro, Wegovy, and Ozempic work, who they're for, their risks, and what alternatives exist — a medically responsible overview.
In this article
GLP-1 receptor agonists — the medication class behind Mounjaro, Wegovy, and Ozempic — are prescription injections that can help some adults lose a meaningful amount of weight by reducing appetite. They are not a quick fix, a substitute for medical supervision, or right for everyone, and using them safely starts with an honest conversation with a doctor.
What Are GLP-1 Weight-Loss Injections?
GLP-1 (glucagon-like peptide-1) is a hormone your gut naturally releases after eating. It signals the brain to reduce appetite and slows how quickly the stomach empties. GLP-1 receptor agonist medications mimic this hormone at a stronger, more sustained level than the body produces on its own.
Established medical practice
This class of medication is approved by major regulatory authorities (including the US FDA and equivalents elsewhere) for type 2 diabetes management and, for some brands specifically, for chronic weight management.
Two related hormone pathways are involved depending on the medication: some (like semaglutide, the active ingredient in Ozempic and Wegovy) act on the GLP-1 receptor alone, while others (like tirzepatide, the active ingredient in Mounjaro) act on both the GLP-1 and GIP receptors together.
Mounjaro, Wegovy, and Ozempic: Different Brands, Different Roles
These three names are often used interchangeably in everyday conversation, but they are not identical:
- Ozempic — semaglutide, approved for type 2 diabetes; sometimes prescribed off-label for weight loss
- Wegovy — semaglutide, at a dose specifically approved for chronic weight management
- Mounjaro — tirzepatide, approved for type 2 diabetes and, in the EU, also for weight management (in the US, the weight-management version has its own brand name)
See our full Mounjaro vs. Wegovy vs. Ozempic comparison for how to think about the differences.
GLP-1 Medications at a Glance
| Brand | Active ingredient | Receptors | EU-authorised for | Form |
|---|---|---|---|---|
| Ozempic | Semaglutide | GLP-1 | Type 2 diabetes | Weekly injection |
| Wegovy | Semaglutide | GLP-1 | Weight management | Weekly injection; the EMA also lists a daily tablet for adults |
| Mounjaro | Tirzepatide | GLP-1 and GIP | Type 2 diabetes and weight management | Weekly injection only |
Weight-management labeling in the EU generally covers adults with obesity (BMI 30 or more), or overweight (BMI 27 and over) with a weight-related condition. Labels differ between countries, and registration in Jordan is a separate question — ask a licensed doctor or pharmacist what is currently registered.
Benefits
For appropriately selected patients, under medical supervision, these medications can lead to clinically meaningful weight loss alongside reduced appetite and improved blood sugar control (for the diabetes-labeled uses). They are typically most effective when combined with nutrition and lifestyle changes rather than used in isolation.
Realistic Results and Timeline
Weight change builds gradually because doses are raised in steps: many people notice reduced appetite within the first weeks, with visible weight change developing over months. In SURMOUNT-5, a 72-week trial in 751 adults with obesity but without diabetes, average weight change was −20.2% with tirzepatide and −13.7% with semaglutide at the maximum tolerated doses. Those are trial averages under close supervision; your own result may be quite different, and no one can promise a number.
Medicines are one part of a plan. The WHO defines obesity as a chronic disease and calls for long-term, multi-part care; see also our BMI calculator, obesity page and guides on protecting muscle, what to eat and plateaus.
Before You Start: Questions to Ask Your Doctor
- Which product and dose schedule are appropriate for my diagnosis, and is it registered where I live?
- Do I have any condition or medicine that rules this out — for example a history of pancreatitis, or insulin or sulfonylurea treatment that raises the risk of low blood sugar?
- Am I pregnant, planning pregnancy or breastfeeding? For Mounjaro, the NHS advises stopping at least four weeks before trying to conceive and using extra barrier contraception after starting and after each dose increase.
- How will side effects, hydration and protein intake be monitored?
- What is the plan for stopping, and for keeping weight off afterwards?
Warning Signs While on Treatment
Seek urgent medical care
Seek urgent medical help for severe or persistent stomach pain that may spread to the back (possible pancreatitis), pain in the upper right abdomen with fever or yellowing skin (possible gallbladder problem), signs of an allergic reaction such as swelling of the face or trouble breathing, symptoms of very low blood sugar such as shakiness, sweating and confusion, or vomiting or diarrhea that will not stop and leaves you unable to keep fluids down.
Are There GLP-1 Pills?
Some semaglutide products exist as daily tablets in some markets — the EMA lists a Wegovy tablet for adults — but there is no approved tirzepatide (Mounjaro) tablet anywhere. That is why the JFDA's warning about "Mounjaro" pills matters: a pill sold under that name is not the real medicine. See Mounjaro and the side-by-side comparison.
Related Guides on JordanMedHub
Who is a candidate · side effects and risks · stopping injections · weight regain after stopping · bariatric surgery vs GLP-1 · weight-loss injection therapy service · endocrinology · nutrition and dietetics
Risks and Side Effects
Nausea, vomiting, diarrhea, and constipation are common, especially when starting treatment or increasing the dose. Less common but more serious risks exist and are discussed in full in our side effects and risks guide — this is not a decision to make without a doctor reviewing your personal and family medical history.
Who Might Be a Candidate
These medications are generally considered for adults with obesity, or with excess weight alongside a weight-related health condition, and are not appropriate for everyone. Our eligibility and medical supervision guide covers this in detail — always a decision made together with a doctor, never a self-directed one.
What Happens If You Stop?
Appetite-suppressing effects fade once the medication is stopped, and weight regain is common without continued lifestyle support. We cover this honestly in what happens after stopping GLP-1 injections and weight regain after stopping.
Alternatives
For some patients, bariatric (weight-loss) surgery is a more suitable or more durable option, particularly at higher BMI levels or when medication isn't appropriate or effective enough — see our bariatric surgery vs. GLP-1 injections comparison for how to think through that choice. A BMI calculation is often a useful starting point for a conversation with a doctor about which path — medication, surgery, or lifestyle-focused care — fits your situation.
Getting GLP-1 Treatment in Jordan
There is currently no oral form of Mounjaro (tirzepatide) approved by regulators anywhere — the only approved form is the injection. This means any pill sold online or on social media as "Mounjaro" is not the genuine, regulator-approved medication, regardless of how it's marketed or packaged.
Separately, as general precaution rather than a specific regulatory finding: treat any pills, online seller, or social-media offer for Wegovy, Ozempic, or Mounjaro with the same skepticism, and don't rely on a pricing or availability claim you see online. As with any prescription medication, it's best to work with a doctor — a licensed endocrinology provider can help — rather than an unverified seller. JordanMedHub does not have verified data on specific pricing or pharmacy availability to publish.
Sources
- Obesity and overweight — WHO fact sheet
- Mounjaro — European Medicines Agency (EPAR)
- Wegovy — European Medicines Agency (EPAR)
- Ozempic — European Medicines Agency (EPAR)
- Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5) — PubMed
- Tirzepatide (Mounjaro) — NHS medicines
- Jordan Food and Drug Administration (JFDA)
Disclaimer
This guide is for general education only and does not diagnose or recommend treatment for any individual. GLP-1 medications require a prescription and ongoing medical supervision. Never start, stop, or change a dose without consulting a doctor.
In this guide
Can GLP-1 Weight-Loss Injections Cause Muscle Loss?
Some lean muscle loss can happen with any significant weight loss, GLP-1 medications included — here's why, how much is typical, and what actually helps.
GLP-1 Weight-Loss Injection Side Effects and Risks: What to Know
Common and serious side effects of GLP-1 medications like Mounjaro, Wegovy, and Ozempic, and when to seek medical attention.
Mounjaro (Tirzepatide): How It Works, Uses, Side Effects, Safety, and Jordan Warning
A medically responsible overview of Mounjaro (tirzepatide) — how it works, what it's approved for, and key things to discuss with your doctor.
Mounjaro vs Wegovy vs Ozempic: Differences, Effectiveness, Side Effects, and Which Suits Whom
A clear, side-by-side look at what separates these three medications — active ingredient, approved use, and how to think about the choice.
Ozempic (Semaglutide): What It's Approved For, and the Weight-Loss Question
Ozempic is approved for type 2 diabetes, not primarily weight loss — here's what that distinction means in practice, and how off-label use works.
Wegovy (Semaglutide): The Weight-Management-Specific GLP-1 Injection
What makes Wegovy different from Ozempic, how it works, who it's approved for, and what to know before starting treatment.
Weight Regain After Stopping GLP-1 Injections: An Honest Look
Why weight regain is common after stopping GLP-1 medications, what the evidence says, and how to reduce the chances of it.
What Happens When You Stop GLP-1 Weight-Loss Injections
What to expect physically after stopping Mounjaro, Wegovy, or Ozempic, and why stopping should be planned with a doctor.
What to Eat While Taking GLP-1 Weight-Loss Injections
Practical, medically responsible nutrition guidance for people taking Mounjaro, Wegovy, or Ozempic — no fad diet, just what actually helps day to day.
Who Is a Candidate for GLP-1 Weight-Loss Injections (and Who Isn't)
General eligibility criteria doctors consider for GLP-1 weight-loss medications, and important contraindications to be aware of.
Why Am I Not Losing Weight on GLP-1 Injections? Understanding Plateaus
A weight-loss plateau on Mounjaro, Wegovy, or Ozempic is common and usually not a sign the medication has stopped working — here's what's actually going on.
Frequently Asked Questions
Are Mounjaro, Wegovy, and Ozempic the same thing?
No. Ozempic and Wegovy both contain semaglutide but are authorised for different uses (diabetes vs. weight management). Mounjaro contains a different active ingredient, tirzepatide, authorised for type 2 diabetes and, in the EU, also for weight management (in the US the weight-management version has its own brand). A doctor can explain which is relevant to your situation.
Can I get a GLP-1 weight-loss injection without a prescription?
No. These are prescription-only medications that require a doctor's evaluation of your health history, and ongoing medical supervision during treatment. Obtaining them without proper medical oversight carries real safety risks.
Is weight loss with these injections permanent?
Not automatically. Weight regain is common after stopping unless supported by lasting lifestyle changes, since these medications manage a chronic condition rather than cure it. See our dedicated guide on stopping treatment and weight regain for a fuller picture.
How much weight can I lose, and when will I start seeing results?
Results vary significantly by individual, medication, and dose, so there's no single number that applies to everyone. Many people notice appetite changes within the first week or two, with visible weight change typically building gradually over the following weeks to months as the dose is increased under medical supervision — it's a gradual process by design, not an immediate effect.
What should I do if I miss a dose?
Guidance differs slightly by medication and is included in the patient information that comes with your prescription — generally, a missed weekly dose can often still be taken if remembered within a few days, otherwise it's skipped and the regular schedule resumed, without doubling up. Always follow your specific medication's instructions or ask your pharmacist or doctor rather than guessing.
Can I buy Wegovy, Ozempic, or Mounjaro in Jordan without seeing a doctor?
For Mounjaro specifically: Jordan's drug regulator, the JFDA, has publicly warned that oral "Mounjaro" pills sold via social media in Jordan are counterfeit and unregistered — the only approved form of that medication is the injection — and has stated that selling medicines online is prohibited in Jordan. That warning is specific to Mounjaro. As general precaution, treat any online offer for Wegovy or Ozempic the same way, and involve a doctor in the decision rather than relying on an unverified seller.
Are there weight-loss pills in this drug class?
Some semaglutide products exist as daily tablets in some markets (the EMA lists a Wegovy tablet for adults), but no tirzepatide (Mounjaro) tablet is approved anywhere. Any pill sold as "Mounjaro" is not the genuine medicine, as the JFDA has warned.
When should I get urgent help while taking a GLP-1 injection?
Get urgent medical help for severe or persistent stomach pain (possible pancreatitis), upper-right abdominal pain with fever or yellow skin, signs of an allergic reaction, symptoms of very low blood sugar, or vomiting or diarrhea that leaves you unable to keep fluids down.
Written by JordanMedHub Medical Editorial Team
Updated
Need to speak with a specialist?
Find a doctor near you to discuss your symptoms and treatment options.
Find a doctor